The New 2019 Institutional Review Board Common Rule Update: Implications for Plastic Surgery Research.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32332559.
- Also identified by DOI 10.1097/PRS.0000000000006752.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical research remains at the forefront of academic practice and evidence-based medicine. Unfortunately, history has shown that human subjects are vulnerable to experimentation without regard for their own dignity and informed decision-making. Subsequently, it is vital for research institutes to uphold safeguards and ethical conscientiousness toward human subjects. The establishment of federal regulations and the development of institutional review boards have set guidance on these processes. On January 21, 2019, final revisions to the Federal Policy for the Protection of Human Subjects (the "Common Rule") went into effect. The purpose of this article is to review changes to the Common Rule and discuss their impact on plastic surgery research.
Medical subject headings
- Biomedical Research
- Ethics Committees, Research
- Human Experimentation
- Research Design
- Surgery, Plastic